关注
García M.L.
García M.L.
在 ub.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
E Sánchez-López, D Gomes, G Esteruelas, L Bonilla, AL Lopez-Machado, ...
Nanomaterials 10 (2), 292, 2020
10252020
Preparation, characterization and biocompatibility studies on risperidone-loaded solid lipid nanoparticles (SLN): high pressure homogenization versus ultrasound
AC Silva, E González-Mira, ML García, MA Egea, J Fonseca, R Silva, ...
Colloids and Surfaces B: Biointerfaces 86 (1), 158-165, 2011
3542011
Current Research Therapeutic Strategies for Alzheimer’s Disease Treatment
J Folch, D Petrov, M Ettcheto, S Abad, E Sánchez-López, ML García, ...
Neural Plasticity 2016, 2016
3302016
Nanomedicines for ocular NSAIDs: safety on drug delivery
J Araújo, E Gonzalez, MA Egea, ML Garcia, EB Souto
Nanomedicine: Nanotechnology, Biology and Medicine 5 (4), 394-401, 2009
3222009
Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation
S Doktorovová, AB Kovačević, ML Garcia, EB Souto
European Journal of Pharmaceutics and Biopharmaceutics 108, 235-252, 2016
2572016
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
A Cano, M Ettcheto, JH Chang, E Barroso, M Espina, BA Kühne, ...
Journal of Controlled Release 301, 62-75, 2019
2442019
Memantine for the treatment of dementia: a review on its current and future applications
J Folch, O Busquets, M Ettcheto, E Sánchez-López, RD Castro-Torres, ...
Journal of Alzheimer's Disease 62 (3), 1223-1240, 2018
2422018
Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications
J Araujo, E Gonzalez-Mira, MA Egea, ML Garcia, EB Souto
International journal of pharmaceutics 393 (1-2), 168-176, 2010
2312010
Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC
E Gonzalez-Mira, MA Egea, ML Garcia, EB Souto
Colloids and Surfaces B: Biointerfaces 81 (2), 412-421, 2010
2292010
Tramadol hydrochloride: Pharmacokinetics, pharmacodynamics, adverse side effects, co-administration of drugs and new drug delivery systems
M Vazzana, T Andreani, J Fangueiro, C Faggio, C Silva, A Santini, ...
Biomedicine & Pharmacotherapy 70, 234-238, 2015
2242015
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: In vitro and in vivo characterization
E Sánchez-López, M Ettcheto, MA Egea, M Espina, A Cano, AC Calpena, ...
Journal of nanobiotechnology 16, 1-16, 2018
2162018
Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery
E Gonzalez-Mira, MA Egea, EB Souto, AC Calpena, ML García
Nanotechnology 22 (4), 045101, 2010
1892010
Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye
J Araújo, S Nikolic, MA Egea, EB Souto, ML Garcia
Colloids and Surfaces B: Biointerfaces 88 (1), 150-157, 2011
1832011
Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC)
S Doktorovová, J Araújo, ML Garcia, E Rakovský, EB Souto
Colloids and Surfaces B: Biointerfaces 75 (2), 538-542, 2010
1782010
Flurbiprofen loaded biodegradable nanoparticles for ophtalmic administration
E Vega, MA Egea, O Valls, M Espina, ML Garcia
Journal of pharmaceutical sciences 95 (11), 2393-2405, 2006
1772006
Current Applications of Nanoemulsions in Cancer Therapeutics
E Sánchez-López, M Guerra, J Dias-Ferreira, A Lopez-Machado, ...
Nanomaterials 9 (6), 821, 2019
1762019
Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs
EB Souto, S Doktorovova, E Gonzalez-Mira, MA Egea, ML Garcia
Current eye research 35 (7), 537-552, 2010
1742010
Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres
J Araújo, E Vega, C Lopes, MA Egea, ML Garcia, EB Souto
Colloids and Surfaces B: Biointerfaces 72 (1), 48-56, 2009
1742009
Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye–Part II-Ocular drug-loaded lipid nanoparticles
E Sánchez-López, M Espina, S Doktorovova, EB Souto, ML García
European Journal of Pharmaceutics and Biopharmaceutics 110, 58-69, 2017
1682017
Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
EB Souto, J Dias-Ferreira, A López-Machado, M Ettcheto, A Cano, ...
Pharmaceutics 11 (9), 460, 2019
1622019
系统目前无法执行此操作,请稍后再试。
文章 1–20